Health-related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone ± subcutaneous daratumumab: Patient-reported outcomes from the APOLLO trial

  1. Terpos, E.
  2. Dimopoulos, M.A.
  3. Boccadoro, M.
  4. Delimpasi, S.
  5. Beksac, M.
  6. Katodritou, E.
  7. Moreau, P.
  8. Pompa, A.
  9. Symeonidis, A.
  10. Bila, J.
  11. Oriol, A.
  12. Mateos, M.-V.
  13. Einsele, H.
  14. Orfanidis, I.
  15. Gries, K.S.
  16. Fastenau, J.
  17. Liu, K.
  18. He, J.
  19. Kampfenkel, T.
  20. Qiu, Y.
  21. Amin, H.
  22. Carson, R.
  23. Sonneveld, P.
Revista:
American Journal of Hematology

ISSN: 1096-8652 0361-8609

Any de publicació: 2022

Volum: 97

Número: 4

Pàgines: 481-490

Tipus: Article

DOI: 10.1002/AJH.26480 GOOGLE SCHOLAR